cyc 202 has been researched along with veliparib in 1 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (veliparib) | Trials (veliparib) | Recent Studies (post-2010) (veliparib) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 325 | 87 | 286 |
| Protein | Taxonomy | cyc 202 (IC50) | veliparib (IC50) |
|---|---|---|---|
| Poly [ADP-ribose] polymerase 1 | Homo sapiens (human) | 0.0469 | |
| Protein mono-ADP-ribosyltransferase PARP10 | Homo sapiens (human) | 1.9027 | |
| Poly [ADP-ribose] polymerase 2 | Homo sapiens (human) | 0.0688 | |
| Protein mono-ADP-ribosyltransferase PARP4 | Homo sapiens (human) | 3.4837 | |
| Protein mono-ADP-ribosyltransferase PARP3 | Homo sapiens (human) | 2.089 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
1 other study(ies) available for cyc 202 and veliparib
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |